Search research articles
Contact Us
Filters
Showing results (251-260 of 480) with videos related to
Page
of 48
Sort By:
Pain
|
November 26, 2020
Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
Timothy Lawn, Yahyah Aman, Katarina Rukavina, et al.
Neurobiology of Aging
|
September 16, 2017
Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5]
Kin Y Mok, Emma L Jones, Marisa Hanney, et al.
JMIR Aging
|
August 25, 2025
Web-Based Assessment of Cognition and Dementia Risk Factors in Over 3000 Norwegian Adults Aged 50 Years and Older: Cross-Sectional PROTECT Norge Study
Ingelin Testad, Jon Arild Aakre, Martha Therese Gjestsen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 22, 2021
Development and assessment of a brief screening tool for psychosis in dementia
Jeffrey L Cummings, Zahinoor Ismail, Bradford C Dickerson, et al.
Neuropathology and Applied Neurobiology
|
July 24, 2015
Unfolded protein response is activated in Lewy body dementias
Jean-Ha Baek, David Whitfield, David Howlett, et al.
International Journal of Geriatric Psychiatry
|
November 17, 2018
An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults
Helen Brooker, Keith A Wesnes, Clive Ballard, et al.
Neurobiology of Disease
|
July 19, 2005
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies
Sally L Pimlott, Margaret Piggott, Clive Ballard, et al.
The Lancet. Neurology
|
February 18, 2018
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
Clive Ballard, Carol Banister, Zunera Khan, et al.
Journal of the American Medical Directors Association
|
August 5, 2015
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis
Clive Ballard, Stuart Isaacson, Roger Mills, et al.
Healthcare (Basel, Switzerland)
|
March 14, 2026
Non-Verbal Communication in Nursing Home Settings
Zunera Khan, Miguel Vasconcelos Da Silva, Daniel Kramarczyk, et al.
Page
of 48
Search research articles
Search
Showing results (251-260 of 480) with videos related to
Sort By:
Page
of 48
Pain
|
November 26, 2020
Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
Timothy Lawn, Yahyah Aman, Katarina Rukavina, et al.
Neurobiology of Aging
|
September 16, 2017
Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5]
Kin Y Mok, Emma L Jones, Marisa Hanney, et al.
JMIR Aging
|
August 25, 2025
Web-Based Assessment of Cognition and Dementia Risk Factors in Over 3000 Norwegian Adults Aged 50 Years and Older: Cross-Sectional PROTECT Norge Study
Ingelin Testad, Jon Arild Aakre, Martha Therese Gjestsen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 22, 2021
Development and assessment of a brief screening tool for psychosis in dementia
Jeffrey L Cummings, Zahinoor Ismail, Bradford C Dickerson, et al.
Neuropathology and Applied Neurobiology
|
July 24, 2015
Unfolded protein response is activated in Lewy body dementias
Jean-Ha Baek, David Whitfield, David Howlett, et al.
International Journal of Geriatric Psychiatry
|
November 17, 2018
An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults
Helen Brooker, Keith A Wesnes, Clive Ballard, et al.
Neurobiology of Disease
|
July 19, 2005
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies
Sally L Pimlott, Margaret Piggott, Clive Ballard, et al.
The Lancet. Neurology
|
February 18, 2018
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
Clive Ballard, Carol Banister, Zunera Khan, et al.
Journal of the American Medical Directors Association
|
August 5, 2015
Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis
Clive Ballard, Stuart Isaacson, Roger Mills, et al.
Healthcare (Basel, Switzerland)
|
March 14, 2026
Non-Verbal Communication in Nursing Home Settings
Zunera Khan, Miguel Vasconcelos Da Silva, Daniel Kramarczyk, et al.
Page
of 48